熱門資訊> 正文

Protalix BioTherapeutics第二季度盈利预览

2026-08-11 23:10

Protalix Biotherapeutics, Inc.(PLX) 0

Protalix BioTherapeutics (PLX) is scheduled to announce Q2 earnings results on Wednesday, August 12th, before market open.
The consensus EPS estimate is -$0.01, and the consensus revenue estimate is $12.93M (-17.4% Y/Y).
Over the last 1 year, PLX has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time.

More on Protalix BioTherapeutics

Protalix BioTherapeutics, Inc. (PLX) Q1 2026 Earnings Call Transcript
Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone
Seeking Alpha’s Quant Rating on Protalix BioTherapeutics
Historical earnings data for Protalix BioTherapeutics
Financial information for Protalix BioTherapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。